# Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders

> **NCT01003145** · NA · COMPLETED · sponsor: **Adimmune Corporation** · enrollment: 292 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza A (H1N1) 2009 monovalent vaccine, inactivated

## Key facts

- **NCT ID:** NCT01003145
- **Lead sponsor:** Adimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003145, "Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01003145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*